Challenge
For the client, a new clinical genomics database (CGDB) unlocked opportunities to streamline genomic data annotation, and make it easier for staff to query, analyze, visualize, and collaborate on annotated genetic variants with clinical data. A solution with faster at-scale utilization of internal clinico-genomic data could improve the company’s testing and reporting capabilities, democratizing data for R&D.
The company’s biopharma partners can leverage CGDB to access its unique datasets, to accelerate drug research and development, identify potential new patient subsets with unmet medical needs, aid in the design of clinical trials, and more.